(0) LAS VEGAS, NV / ACCESSWIRE / April 15, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), the 'Company' or 'CLS', a diversified cannabis company operating as Cannabis Life Sciences, today announced its operational and financial results for the third quarter of fiscal 2021, ended February 28, 2021. Key Q3 Financial & Operational Accomplishments CLS continues to outperform operationally, achieving a 44.7% increase in total revenue in the first nine months of fiscal 2021 compared to the comparable period of fiscal 2020. The Company achieved total revenue of $4,544,082 for the quarter ended February 28, 2021 - a 40.9% increase over the quarter ended February 29, 2020. Gross margin for the quarter was 45.2%, and 51% for the nine month period ended February 28, 2021 compared to gross margin of 52.3% and 50.4% respectively, for the comparable period during fiscal 2020.